Paper · 42840132
Methylprednisolone sodium succinate combined with azithromycin in the treatment of Mycoplasma pneumonia in children and Its effect on immune function.
Zhang Q and 2 others. Front Pediatr, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Methylprednisolone sodium succinate combined with azithromycin in the treatment of Mycoplasma pneumonia in children and Its effect on immune function. Papers, record 42840132. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42840132
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Methylprednisolone sodium succinate combined with azithromycin in the treatment of Mycoplasma pneumonia in children and Its effect on immune function.
- Journal
- Front Pediatr
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-08
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40,107,784 | [Epidemiological characteristics of co-infection with drug-resistant Mycoplasma pneumoniae and non-bacterial pathogens in a children's hospital in Ningbo City from 2021 to 2024]. | Zhonghua Yu Fang Yi Xue Za Zhi | 2025 | https://conductscience.org/library/papers/40107784 | PubMed |
| 2 | 33,412,618 | [Focus on the difficulties and challenges in the diagnosis and treatment of Mycoplasma pneumoniae pneumonia]. | Zhonghua Jie He He Hu Xi Za Zhi | 2021 | https://conductscience.org/library/papers/33412618 | PubMed |
| 3 | 33,663,659 | [Application of Methylprednisolone Sodium Succinate Combined with Tropisetron in Prevention of Nausea and Vomiting under Microvascular Decompression of Hemifacial Spasm]. | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | 2021 | https://conductscience.org/library/papers/33663659 | PubMed |
| 4 | 38,114,220 | [Characteristic changes of blood stasis syndrome in rat model of steroid-induced femoral head necrosis based on the combination of disease, syndrome, and symptom]. | Zhongguo Zhong Yao Za Zhi | 2023 | https://conductscience.org/library/papers/38114220 | PubMed |
| 5 | 35,718,548 | Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection. | Med Clin (Barc) | 2022 | https://conductscience.org/library/papers/35718548 | PubMed |
| 6 | 30,966,992 | Exogenous glucocorticoids amplify the costs of infection by reducing resistance and tolerance, but effects are mitigated by co-infection. | Proc Biol Sci | 2019 | https://conductscience.org/library/papers/30966992 | PubMed |
| 7 | 39,192,444 | [Clinical characteristics and predictive factors for plastic bronchitis in children with severe Mycoplasma pneumoniae pneumonia]. | Zhonghua Er Ke Za Zhi | 2024 | https://conductscience.org/library/papers/39192444 | PubMed |
| 8 | 32,481,378 | Efficacy and safety of azithromycin combined with glucocorticoid on refractory Mycoplasma pneumoniae pneumonia in children: A PRISMA-compliant systematic review and meta-analysis. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32481378 | PubMed |
| 9 | 35,325,564 | Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review. | Viral Immunol | 2022 | https://conductscience.org/library/papers/35325564 | PubMed |
| 10 | 38,708,969 | Age-related effects of Mycoplasma pneumoniae infection and subsequent asthma exacerbation in children. | Pediatr Pulmonol | 2024 | https://conductscience.org/library/papers/38708969 | PubMed |
1 to 10 of 33
See all 33 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42840132
GET https://conductscience.org/api/papers/v1/42840132/references?page=2